The purpose of this statement is to provide consensus-based recommendations for optimal
management and care for patients with primary mitochondrial disease. This statement is …

Mitochondrial complex V (CV) generates cellular energy as adenosine triphosphate (ATP).
Mitochondrial disease caused by the m.8993T>G pathogenic variant in the CV subunit gene …

Mitochondria are critical for the provision of ATP for cellular energy requirements. Tissue
and organ functions are dependent on adequate ATP production, especially when energy …

The synthesis of all 13 mitochondrial DNA (mtDNA)-encoded protein subunits of the human
oxidative phosphorylation (OXPHOS) system is carried out by mitochondrial ribosomes (…

The neurodiagnostic criteria of Leigh syndrome have not yet been clearly redefined based
on the expanding of molecular etiologies. We aimed to analyze 20 years of clinical, genetic, …

Objective Primary mitochondrial diseases (PMDs) are heterogeneous disorders caused by
inherited mitochondrial dysfunction. Classically defined neuropathologically as subacute …

Objective To determine changes in motor and respiratory function after treatment with
nusinersen in adults with spinal muscular atrophy (SMA) during the first two years of commercial …

Broad-based exome sequencing has become the standard first-line diagnostic approach for
PMD. This has facilitated more rapid and accurate disease identification, and greatly …

Background Clinical treatment trials are increasingly being designed in primary mitochondrial
disease (PMD), a phenotypically and genetically heterogeneous collection of inherited …

Objective To investigate the safety and efficacy of escalating doses of the semi-synthetic
triterpenoid omaveloxolone in patients with mitochondrial myopathy. Methods In cohorts of 8–13…